Neutralizing TNF-α when MPO-specific Th1 immune responses were established in anti-MPO GN (day 32; Figure 2A) significantly attenuated kidney damage compared to control-treated mice, assessed by albuminuria (Figure 2B) and glomerular segmental necrosis (Figure 2C). The gene discussed is MPO; the disease is ganglioneuroma.